Chemotherapy management of a pediatric B-ALL patient with moyamoya disease: a case report.
Moyamoya disease is a rare, chronic cerebrovascular disorder characterized by progressive stenosis or occlusion of the terminal portions of the internal carotid arteries and the subsequent development
APA
Cheng YR, Han J, et al. (2026). Chemotherapy management of a pediatric B-ALL patient with moyamoya disease: a case report.. Frontiers in oncology, 16, 1733347. https://doi.org/10.3389/fonc.2026.1733347
MLA
Cheng YR, et al.. "Chemotherapy management of a pediatric B-ALL patient with moyamoya disease: a case report.." Frontiers in oncology, vol. 16, 2026, pp. 1733347.
PMID
41800045
Abstract
Moyamoya disease is a rare, chronic cerebrovascular disorder characterized by progressive stenosis or occlusion of the terminal portions of the internal carotid arteries and the subsequent development of abnormal compensatory vascular networks. It represents a significant cause of intracranial arteriopathy and is a major etiology of stroke and transient ischemic attack in pediatric populations. We present the case of a 9-year-old boy with confirmed diagnosis of B-cell acute lymphoblastic leukemia (B-ALL), in whom brain MRI findings were suggestive of Moyamoya disease. This report underscores the rarity of the co-occurrence of B-ALL and Moyamoya disease and highlights the importance of early recognition and timely intervention during chemotherapy to reduce the risk of neurological complications. Our findings may offer valuable insights for the chemotherapeutic management of ALL patients with coexisting Moyamoya disease.